PREDICTION MODEL FOR THE TREATMENT OF VENOUS LEG ULCERS
腿部静脉溃疡治疗的预测模型
基本信息
- 批准号:2732476
- 负责人:
- 金额:$ 10.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-09-15 至 2000-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Venous leg ulcers account for 40 to 70% of all chronic wounds, afflict
1 million Americans per year, and standard treatment for these patients
is estimated to cost more than l billion dollars per year. The current
standard therapy for these wounds is a limb compression bandage, which
at best has a success rate of 70 to 80%. Very little information exists
that can be used to predict who will have a successful outcome. The
hypothesis of this proposal is that there are identifiable risk factors
that can be used to predict which individuals will have a successful
outcome. A statistically powerful prediction model will be created using
logistic regression analysis based on a dataset derived from the
candidate's clinical practice and the control inns of industry sponsored
trials. This model will be validated using a split sample technique, and
by a prospective study in Penn's Cutaneous Ulcer Center. It will provide
information that will guide the design of studies to evaluate new
therapies, establish relationships between risk factor and wound healing
which will lead to properly controlled hypothesis driven research, and
may demonstrate two clinically distinct subsets of patients with venous
led ulcers.
腿部静脉性溃疡占所有慢性伤口的 40% 至 70%
每年有 100 万美国人,以及这些患者的标准治疗
估计每年花费超过l十亿美元。目前的
这些伤口的标准疗法是肢体加压绷带,
最好的情况下成功率只有70%到80%。 存在的信息很少
可以用来预测谁会取得成功的结果。这
该提案的假设是存在可识别的风险因素
可以用来预测哪些人会取得成功
结果。将使用以下方法创建统计上强大的预测模型
基于数据集的逻辑回归分析
候选人的临床实践和行业赞助的控制旅馆
试验。该模型将使用分割样本技术进行验证,并且
宾夕法尼亚大学皮肤溃疡中心的一项前瞻性研究。它将提供
指导研究设计以评估新产品的信息
治疗,建立危险因素和伤口愈合之间的关系
这将导致适当控制的假设驱动的研究,以及
可能会证明静脉血栓患者的两个临床上不同的子集
导致溃疡。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Margolis其他文献
David Margolis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Margolis', 18)}}的其他基金
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
- 批准号:
10296086 - 财政年份:2021
- 资助金额:
$ 10.64万 - 项目类别:
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
- 批准号:
10470869 - 财政年份:2021
- 资助金额:
$ 10.64万 - 项目类别:
Comparative effectiveness of spironolactone versus oral tetracycline-class antibiotics for the treatment of moderate to severe acne in women
螺内酯与口服四环素类抗生素治疗女性中度至重度痤疮的疗效比较
- 批准号:
9815052 - 财政年份:2019
- 资助金额:
$ 10.64万 - 项目类别:
NOS1AP and Capon Associated Impaired Healing in Those with Diabetic Foot Ulcers
NOS1AP 和 Capon 与糖尿病足溃疡患者的愈合受损相关
- 批准号:
9925084 - 财政年份:2018
- 资助金额:
$ 10.64万 - 项目类别:
African-Americans with Atopic Dermatitis: Skin Barrier and Immune
患有特应性皮炎的非裔美国人:皮肤屏障和免疫
- 批准号:
9228322 - 财政年份:2016
- 资助金额:
$ 10.64万 - 项目类别:
African-Americans with Atopic Dermatitis: Skin Barrier and Immune
患有特应性皮炎的非裔美国人:皮肤屏障和免疫
- 批准号:
9868281 - 财政年份:2016
- 资助金额:
$ 10.64万 - 项目类别:
Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
- 批准号:
8538377 - 财政年份:2012
- 资助金额:
$ 10.64万 - 项目类别:
Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
- 批准号:
8370929 - 财政年份:2012
- 资助金额:
$ 10.64万 - 项目类别:














{{item.name}}会员




